Medical weight loss continues to evolve as science advances our understanding of metabolism, appetite regulation, and long-term weight management. A major milestone in this field is the recent approval of an oral GLP-1 medication for chronic weight management, offering a non-injectable option for adults seeking physician-guided support for weight loss and metabolic health.
At BODYWELLE in Miami Beach, Dr. Alonso Martin now offers oral Wegovy weight loss medication as part of a comprehensive, evidence-based medical weight loss program. This treatment reflects a shift toward safer, more accessible options that support sustainable weight management while prioritizing long-term health.
GLP-1 medications have played a growing role in medical weight management due to their ability to influence appetite, satiety, and metabolic signaling. Until recently, these therapies were only available as injections. The approval of an oral GLP-1 medication for weight management represents an important step forward for patients who prefer a pill-based approach or who may not be ideal candidates for injectable treatments.
Oral Wegovy is prescribed under physician supervision and integrated into a broader medical strategy rather than offered as a standalone solution. At BODYWELLE, this approach allows treatment plans to be tailored based on goals, symptoms, performance needs, recovery requirements, and lifestyle, while maintaining a clear focus on safety and long-term outcomes.
Before and after outcomes from medically guided weight loss treatment
Oral Wegovy is a prescription medication designed to support weight management in adults with obesity, as well as in certain adults who are overweight and have weight-related health concerns, when used as part of a medically supervised program. It belongs to a class of medications known as GLP-1 receptor agonists, which work by mimicking a naturally occurring hormone involved in appetite regulation and glucose control.
Unlike injectable GLP-1 medications, this formulation is taken by mouth, offering an alternative for patients who prefer oral dosing. The medication is prescribed only after medical evaluation and ongoing monitoring to ensure appropriate use and patient safety.
By influencing these pathways, oral GLP-1 therapy helps patients make meaningful dietary changes more sustainably. Rather than relying on willpower alone, the medication supports the body’s natural signaling systems, which may make long-term weight management more achievable when combined with medical oversight.
At BODYWELLE, treatment plans are customized based on individual goals, symptoms, performance needs, recovery requirements, and lifestyle, ensuring the medication is used as part of a broader health strategy rather than in isolation.
Oral Wegovy is intended for adults who meet specific medical criteria for prescription weight management therapy. Candidacy is determined through a comprehensive medical evaluation, not a one-size-fits-all approach.
Patients who may be considered include adults who:
I can’t express enough how grateful I am for the life-changing results I’ve experienced at AM Beauty + Wellness. This clinic and Dr. Alonso have given me not just a slimmer figure, but a whole new lease on life. If you’re struggling with weight or simply want to invest in your health, I cannot recommend this place highly enough. It’s hands down the best thing I’ve ever done for myself.
— Orlando S.
I was getting up 4 to 5 times per night to go to the bathroom. I was tired all the time. Right away I noticed better control. Now I have nights I do not get up at all.
— Mikaela
I couldn’t do jump rope competitions. I would think about things that I couldn’t do. By my 3rd treatment I could sneeze and feel nothing. It’s freeing to do what you want to do again.
— Megan
During consultation, Dr. Martin reviews these differences in detail to help determine which option aligns best with a patient’s medical needs, preferences, and long-term health goals. Treatment selection is guided by safety, effectiveness, and sustainability rather than convenience alone.
Patient safety is central to any medical weight loss program. Oral Wegovy is prescribed with careful attention to dosing, monitoring, and follow-up. Like all prescription medications, it may cause side effects, particularly during the early stages of treatment as the body adjusts.
Potential side effects may include:
Each treatment plan is tailored to the individual’s goals, symptoms, performance needs, recovery requirements, and lifestyle, allowing care to evolve as health improves over time.
Beginning oral Wegovy treatment starts with a comprehensive medical consultation. At BODYWELLE, Dr. Alonso Martin takes a physician-guided approach to weight management, ensuring that every treatment plan is based on a patient’s health history, metabolic profile, and long-term goals.
During consultation, patients undergo a thorough evaluation that may include a review of medical history, current medications, weight-related health concerns, and prior weight loss efforts. This process allows Dr. Martin to determine whether oral GLP-1 therapy is appropriate and how it may fit into a broader medical weight loss strategy.
Follow-up visits are an essential part of care, allowing treatment plans to be adjusted over time based on response, tolerance, and overall health. In some cases, virtual consultations may be available for appropriate patients, offering added flexibility while maintaining physician oversight.
By emphasizing consultation and ongoing monitoring, BODYWELLE ensures that medical weight loss treatment remains safe, individualized, and focused on long-term health rather than short-term outcomes.
Sustainable weight management extends beyond the number on a scale. Oral Wegovy is used to support broader metabolic health goals, including appetite regulation, improved dietary adherence, and healthier eating patterns over time.
By addressing hormonal signals involved in hunger and satiety, GLP-1 therapy may help patients develop more consistent habits that support long-term success. Dr. Martin emphasizes that medication works best when combined with medical guidance, nutritional awareness, and realistic lifestyle adjustments.
This balanced approach helps patients focus on healthspan, energy, and overall well-being rather than short-term outcomes alone.
BODYWELLE has established a reputation for physician-led, patient-centered medical weight loss care focused on safety, personalization, and long-term health. Dr. Martin’s experience in medical weight management allows him to integrate new therapies thoughtfully, ensuring that treatment decisions align with current evidence and patient safety.
Every patient is evaluated individually, and treatment decisions are made collaboratively, with transparency and education at the forefront.
If you are exploring medically guided weight loss and want to learn whether oral Wegovy weight loss medication may be appropriate for you, a consultation at BODYWELLE is the next step. Dr. Alonso Martin provides individualized evaluation, evidence-based guidance, and ongoing support focused on safety and long-term health.
Consultations are available in Miami Beach, with telemedicine options for eligible patients.
Yes. The medication has received approval from the U.S. Food and Drug Administration for chronic weight management in adults who meet specific medical criteria. It is prescribed under physician supervision as part of a comprehensive treatment plan.
Individual responses vary. Some patients notice appetite changes early, while weight changes occur gradually over time. Dr. Martin emphasizes realistic timelines and long-term progress rather than rapid results.
No. The medication is designed to support lifestyle changes, not replace them. It works best when combined with medical guidance, nutritional awareness, and sustainable habits.
Duration of treatment depends on individual goals, response, and medical considerations. Ongoing monitoring helps determine the most appropriate treatment course for each patient.
A medical consultation is the first step. Dr. Martin reviews health history, goals, and potential risks to determine whether oral Wegovy or another approach is appropriate.
